189 related articles for article (PubMed ID: 19011808)
1. Omenn syndrome with mutation in RAG1 gene.
Jaouad IC; Ouldim K; Ali Ou Alla S; Kriouile Y; Villa A; Sefiani A
Indian J Pediatr; 2008 Sep; 75(9):944-6. PubMed ID: 19011808
[TBL] [Abstract][Full Text] [Related]
2. Omenn syndrome--review of several phenotypes of Omenn syndrome and RAG1/RAG2 mutations in Japan.
Kato M; Kimura H; Seki M; Shimada A; Hayashi Y; Morio T; Kumaki S; Ishida Y; Kamachi Y; Yachie A
Allergol Int; 2006 Jun; 55(2):115-9. PubMed ID: 17075247
[TBL] [Abstract][Full Text] [Related]
3. Omenn syndrome due to ARTEMIS mutations.
Ege M; Ma Y; Manfras B; Kalwak K; Lu H; Lieber MR; Schwarz K; Pannicke U
Blood; 2005 Jun; 105(11):4179-86. PubMed ID: 15731174
[TBL] [Abstract][Full Text] [Related]
4. [Clinical phenotype and gene diagnostic analysis of Omenn syndrome].
Wang YQ; Cui YX; Feng J
Zhonghua Er Ke Za Zhi; 2013 Jan; 51(1):64-8. PubMed ID: 23527934
[TBL] [Abstract][Full Text] [Related]
5. Omenn Syndrome due to RAG1 Mutation Presenting With Nonimmune Hydrops Fetalis in Two Siblings.
Valeri L; Lugli L; Iughetti L; Soresina A; Giliani S; Porta F; Berardi A
Pediatrics; 2022 Jan; 149(1):. PubMed ID: 34889447
[TBL] [Abstract][Full Text] [Related]
6. [Omenn Syndrome and DNA recombination defects].
Yachie A
Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(3):179-189. PubMed ID: 28747605
[TBL] [Abstract][Full Text] [Related]
7. Omenn Syndrome Presenting with Striking Erythroderma and Extreme Lymphocytosis in a Newborn.
Zafar R; Ver Heul A; Beigelman A; Bednarski JJ; Bayliss SJ; Dehner LP; Rosman IS; Coughlin CC
Pediatr Dermatol; 2017 Jan; 34(1):e37-e39. PubMed ID: 27862277
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics and molecular analysis of three Chinese children with Omenn syndrome.
Zhang ZY; Zhao XD; Jiang LP; Liu EM; Cui YX; Wang M; Wei H; Yu J; An YF; Yang XQ
Pediatr Allergy Immunol; 2011 Aug; 22(5):482-7. PubMed ID: 21771083
[TBL] [Abstract][Full Text] [Related]
9. Mutation c.256_257delAA in RAG1 Gene in Polish Children with Severe Combined Immunodeficiency: Diversity of Clinical Manifestations.
Szaflarska A; Rutkowska-Zapała M; Kotula M; Gruca A; Grabowska A; Lenart M; Surman M; Trzyna E; Mordel A; Pituch-Noworolska A; Siedlar M
Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):177-183. PubMed ID: 28083621
[TBL] [Abstract][Full Text] [Related]
10. Omenn syndrome caused by a novel homozygous mutation in recombination activating gene 1.
Benhsaien I; Essadssi S; Elkhattabi L; Bakhchane A; Abdelghaffar H; Bousfiha AA; Badou A; Barakat A
Immunobiology; 2021 May; 226(3):152090. PubMed ID: 33964732
[TBL] [Abstract][Full Text] [Related]
11. Mutations in Recombination Activating Gene 1 and 2 in patients with severe combined immunodeficiency disorders in Egypt.
Meshaal S; El Hawary R; Elsharkawy M; Mousa RK; Farid RJ; Abd Elaziz D; Alkady R; Galal N; Massaad MJ; Boutros J; Elmarsafy A
Clin Immunol; 2015 Jun; 158(2):167-73. PubMed ID: 25869295
[TBL] [Abstract][Full Text] [Related]
12. Diagnosing Omenn syndrome.
Cutts L; Bakshi A; Walsh M; Parslew R; Eustace K
Pediatr Dermatol; 2021 Mar; 38(2):541-543. PubMed ID: 33511666
[TBL] [Abstract][Full Text] [Related]
13. Clinical, immunologic, and genetic characteristics of RAG mutations in 15 Chinese patients with SCID and Omenn syndrome.
Bai X; Liu J; Zhang Z; Liu C; Zhang Y; Tang W; Dai R; Wu J; Tang X; Zhang Y; Ding Y; Jiang L; Zhao X
Immunol Res; 2016 Apr; 64(2):497-507. PubMed ID: 26476733
[TBL] [Abstract][Full Text] [Related]
14. Mutations in CHD7 in patients with CHARGE syndrome cause T-B + natural killer cell + severe combined immune deficiency and may cause Omenn-like syndrome.
Gennery AR; Slatter MA; Rice J; Hoefsloot LH; Barge D; McLean-Tooke A; Montgomery T; Goodship JA; Burt AD; Flood TJ; Abinun M; Cant AJ; Johnson D
Clin Exp Immunol; 2008 Jul; 153(1):75-80. PubMed ID: 18505430
[TBL] [Abstract][Full Text] [Related]
15. Clinical Manifestations, Mutational Analysis, and Immunological Phenotype in Patients with RAG1/2 Mutations: First Cases Series from Mexico and Description of Two Novel Mutations.
Lugo-Reyes SO; Pastor N; González-Serrano E; Yamazaki-Nakashimada MA; Scheffler-Mendoza S; Berron-Ruiz L; Wakida G; Nuñez-Nuñez ME; Macias-Robles AP; Staines-Boone AT; Venegas-Montoya E; Alaez-Verson C; Molina-Garay C; Flores-Lagunes LL; Carrillo-Sanchez K; Niemela J; Rosenzweig SD; Gaytan P; Yañez JA; Martinez-Duncker I; Notarangelo LD; Espinosa-Padilla S; Cruz-Munoz ME
J Clin Immunol; 2021 Aug; 41(6):1291-1302. PubMed ID: 33954879
[TBL] [Abstract][Full Text] [Related]
16. Omenn syndrome: a disorder of Rag1 and Rag2 genes.
Villa A; Santagata S; Bozzi F; Imberti L; Notarangelo LD
J Clin Immunol; 1999 Mar; 19(2):87-97. PubMed ID: 10226883
[TBL] [Abstract][Full Text] [Related]
17. Compound heterozygous mutation of Rag1 leading to Omenn syndrome.
Matthews AG; Briggs CE; Yamanaka K; Small TN; Mooster JL; Bonilla FA; Oettinger MA; Butte MJ
PLoS One; 2015; 10(4):e0121489. PubMed ID: 25849362
[TBL] [Abstract][Full Text] [Related]
18. A Large Cohort of RAG1/2-Deficient SCID Patients-Clinical, Immunological, and Prognostic Analysis.
Greenberg-Kushnir N; Lee YN; Simon AJ; Lev A; Marcus N; Abuzaitoun O; Somech R; Stauber T
J Clin Immunol; 2020 Jan; 40(1):211-222. PubMed ID: 31838659
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of genetic mutations and pathogenesis for two children with Omenn syndrome].
Xu Y; Chen Y; Chen H; Zeng H
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Feb; 33(1):38-43. PubMed ID: 26829731
[TBL] [Abstract][Full Text] [Related]
20. Analysis of mutations and recombination activity in RAG-deficient patients.
Asai E; Wada T; Sakakibara Y; Toga A; Toma T; Shimizu T; Nampoothiri S; Imai K; Nonoyama S; Morio T; Muramatsu H; Kamachi Y; Ohara O; Yachie A
Clin Immunol; 2011 Feb; 138(2):172-7. PubMed ID: 21131235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
